Charlotte Kloft was awarded for her innovative team work on ”Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model“ (in Mueller-Schoell et al. Cancers 2021). Together with colleagues from the MD Andersson Cancer Center in Texas/US, Charité-Universitaetsmedizin Berlin and Wilhelm Huisinga from the Universität Potsdam, she developed with her team a mathematical model to early predict success of the innovative CAR-T cell therapy for the individual patient.
Further information: including a short video with the awardee and on the ceremony and on the award and the project.